Centinel Spine Announces Lumbar Total Disc Replacement coverage by TRICARE

prodiscLCoverModelNew York, NY, June 14, 2018 Centinel Spine, LLC is pleased to announce that TRICARE, the Military Health System for almost 10 million beneficiaries world-wide, has updated its coverage policy to now cover the company’s prodisc® L Anterior Lumbar Total Disc Replacement system, the most studied total disc replacement platform in the world.  More patients globally now have access to this market leading technology, a potential alternative to spinal fusion that is designed to relieve pain, maintain spinal motion and reduce post-operative recuperation time. The TRICARE extended coverage has far-reaching impact as it applies to both active duty and retired military personnel.  “With years of total disc replacement experience, I have witnessed extreme patient recovery with this technology.  This extended coverage policy will provide more patients with access to a proven surgery that offers better mobility and faster return to an active lifestyle,” stated spine surgeon Robert Masson, M.D. (Masson Spine Institute, Orlando FL).

Continue reading “Centinel Spine Announces Lumbar Total Disc Replacement coverage by TRICARE”

Centinel Spine Announces 510(k) Clearance of FLX™ Platform of 3D Printed All-Titanium Interbodies

New York, NY, June 7, 2018 Centinel Spine, LLC is pleased to announce that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its FLX™ Platform of Integrated Interbody™ and non-integrated interbody fusion devices.  Centinel Spine is the largest privately-held spine company, focused on anterior column reconstruction.

FLX-GridFLX devices are 3D-printed, all-titanium devices which feature a combination of solid and porous radiolucent sections designed to reduce mechanical stiffness and improve visibility, compared to solid titanium implants.  The devices also feature a proprietary FUSE-THRU™ trabecular scaffold, designed to allow for bony in-growth and on-growth throughout the implant.

“We are excited to announce the clearance of the FLX Platform, which represents the next evolution in STALIF technology.  Utilizing 3D-printing, we are able to offer the proven benefits of the STALIF design in a truly novel, all-titanium lattice option.  This allows our surgeons the flexibility to use multiple implant material options through a single set of instruments to address each patient’s unique pathology,” says Centinel Spine Chairman & CEO, John Viscogliosi.

Continue reading “Centinel Spine Announces 510(k) Clearance of FLX™ Platform of 3D Printed All-Titanium Interbodies”

Centinel Spine Announces Partnership with PGA Tour Winner Brian Gay

New York, NY, March 20, 2018 Centinel Spine, LLC is pleased to announce that it has entered into an endorsement agreement with four time PGA Tour Winner, Brian Gay. This partnership brings together two leaders in their field, with the goal of educating high performing individuals that spinal injury and disease does not require living with pain or negatively affect an active lifestyle. This collaboration will demonstrate to patients throughout the world that the lumbar and cervical products provided by Centinel Spine have the potential to give them back their life.

Brian HeadshotCentinel Spine, the pioneer of the No-Profile®, Integrated Interbody™ has a 30 year global clinical history of success behind these devices for treatment of degenerative disc disease.  The company recently announced the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio. The prodisc line of products represents the most extensive total disc replacement (TDR) portfolio in the world with the longest history of use.  The acquisition is the next step in the evolution of Centinel Spine executing on its mission to become the worldwide leading company addressing spinal disease through anterior access to the spine with the widest breadth and depth of technology platforms.

The partnership with PGA Tour golfer Brian Gay opens up a new type of athlete and patient population that Centinel Spine Chairman & CEO John Viscogliosi can reach and educate. “Centinel Spine’s mission is to address spinal disease and allow individuals to continue to function at a high level, even after major spine surgery,” said Viscogliosi. “The prodisc system was purposefully designed to allow patients to return to their lives faster and with the peace of mind that the implant will restore natural motion for the long-term. Centinel Spine is proud to be partnered with Brian Gay.”

Continue reading “Centinel Spine Announces Partnership with PGA Tour Winner Brian Gay”

Centinel Spine and Performance Tech Announce Plan for a Season of Success!

New York, NY, February 14, 2018 Centinel Spine, LLC is pleased to announce that it has extended an endorsement agreement with Performance Tech Motorsports for the entirety of the 2018 IMSA WeatherTech SportsCar Championship season.  Centinel Spine first joined the Performance Tech family in January for the Rolex 24 At Daytona.  This partnership will support the creation of a platform to educate the public on spinal disease and options that allow individuals to continue to function at a high level.

Rolex-24

Centinel Spine, the pioneer of the No-Profile®, Integrated Interbody™ has a 30 year global clinical history of success behind these devices for treatment of degenerative disc disease.  The company recently announced the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio. The prodisc line of products represents the most extensive total disc replacement (TDR) portfolio in the world with the longest history of use.  The acquisition is the next step in the evolution of Centinel Spine executing on its mission to become the worldwide leading company addressing spinal disease through anterior access to the spine with the widest breadth and depth of technology platforms.

Performance Tech opens up a new type of athlete and patient population that Centinel Spine Chairman & CEO John Viscogliosi can reach and educate. Performance Tech and Team Principal Brent O’Neill are readily supplying athletes to Centinel Spine for examples of athleticism and the wear of high performance endurance.

Continue reading “Centinel Spine and Performance Tech Announce Plan for a Season of Success!”

Performance Tech Teams with Centinel Spine for Rolex 24

DEERFIELD BEACH, Fla. (Jan. 16, 2018) – Performance Tech Motorsports is teaming up with Centinel Spine for the Rolex 24 At Daytona with an effort to bring together two technological leaders with the IMSA WeatherTech SportsCar Championship.

CENT_PerformanceTech_RacingSponsorship_FrontMockup_v3

Centinel Spine develops, manufactures, and distributes products used by spinal surgeons across the world. The company was founded in 2008 after the merger-acquisition of Raymedica, LLC and Surgicraft LTD, two pioneering medical device companies. Today, with over 31 years of experience Centinel Spine has implanted over 46,000 devices.

Centinel Spine’s partnership with Performance Tech comes with a hefty goal. To educate not just fans, but the hundreds of athletes under the IMSA banner that spinal injury and disease doesn’t have to end your career nor should you have to live with pain and downgrade your lifestyle. Every day patients are sharing their success story on how the multiple Centinel Spine products concerning both lumbar and cervical gave them their life back.

Continue reading “Performance Tech Teams with Centinel Spine for Rolex 24”

Centinel Spine Announces the Acquisition of the Worldwide Assets of the prodisc Total Disc Replacement Portfolio

New York, NY, December 21, 2017 – Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy Synthes Products, Inc. The prodisc line of products are total disc replacement (TDR) products with the longest history of use globally. The prodisc portfolio includes prodisc® C and prodisc® L in the United States and prodisc® VIVO, prodisc® NOVA, prodisc C, prodisc L, and prodisc® O, along with DISCOVER™ Cervical outside the United States.

12-20-17_image

This acquisition complements Centinel Spine’s existing spinal implant portfolio of leading technologies for anterior column support of the spine from cervical to lumbar. This includes the company’s standalone portfolio of STALIF C®, STALIF C-Ti™, MIDLINE II™, MIDLINE II-Ti™, and STALIF L™, as well as additional products ACTILIF™ Cervical Cage TRANSOM™ Plate, and ALTOS® PCT.

Centinel Spine, the pioneer of the No-Profile®, Integrated Interbody™ has a 30 year history of developing integrated interbody devices into a standard treatment for patients with degenerated disc disease. Centinel Spine will utilize the same clinical, regulatory, and development expertise to broaden acceptance and to increase carrier coverage and surgeon adoption of total discs worldwide.

“This transaction is the next step in the evolution of Centinel Spine executing on its mission to become the worldwide leading company addressing spinal disease through anterior access to the spine with the widest breadth and depth of technology platforms,” said John J. Viscogliosi, Centinel Spine Chairman & CEO.

For background in understanding the acquisition, Viscogliosi Brothers, LLC, a lead investor in Centinel Spine, was the founder of Spine Solutions, Inc., the company that led the original IDE study to bring prodisc to the United States.

The company also completed debt and equity financing to close on the transaction and provide working capital. Piper Jaffray & Co. served as the sole placement agent for Centinel Spine.

About Centinel Spine, LLC.

Centinel Spine, LLC. is a privately-held spinal device company leading the development and commercialization of the No- Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.CentinelSpine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:

Varun Gandhi
SVP, Corporate Finance & Strategic Planning Centinel Spine, LLC
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: v.gandhi@centinelspine.com

Wendy F. DiCicco
Chief Operating and Chief Financial Officer Centinel Spine, LLC
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8837
Email: w.dicicco@centinelspine.com

Centinel Spine® Granted Australian Clearance for STALIF L™ Minimally-Invasive, Lateral Integrated Interbody™ System

6-20-16_image1New York, NY, June 23, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of the No- Profile, Integrated Interbody™ fusion device market, is granted clearance for STALIF L™ No- Profile, Lateral Lumbar Integrated Interbody system by the Australian Therapeutic Goods Administration.

“This clearance expands our International No-Profile, Integrated Interbody market,” said John J. Viscogliosi, Chairman & CEO, Centinel Spine. “STALIF has enjoyed a long successful history in Australia and now STALIF L exemplifies our continued commitment to being the gold standard in Integrated Interbody devices. We are excited to bring the STALIF advantage to minimally-invasive spinal fusion surgery in Australia,” Mr. Viscogliosi continued.

STALIF L continues the thirty-year STALIF® heritage of innovation as STALIF L is the only lateral device to offer the benefits of no-profile, compressive lag fixation with proprietary anti-backout technology and 12-degrees of lordosis.

In addition to the above-mentioned STALIF benefits, STALIF L also offers a large chamber for bone graft to support fusion, optimized fixation with easily placed self-drilling, self-tapping screws and a variety of cage sizes to match patient anatomy.

Sam Scott-Young, Managing Director, Orthotech Orthopaedics Holdings, Ltd, Pty, exclaimed, “Orthotech is proud to represent Centinel Spine in Australia. We are excited to receive the STALIF L clearance enabling us to provide this innovative technology to our surgeon customers and their spine surgery patients. ”

Mr. Scott-Young continued, “The entire STALIF product portfolio, including the new STALIF L, and the Ti-ACTIVE™ technology, a texturized, titanium coating, allows our surgeon customers to offer their patients the most up-to-date spinal technologies with a heritage of more than 25 years of proven clinical success as a treatment for degenerative spinal pathologies.”

Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C®, STALIF C-Ti™, MIDLINE II™ and MIDLINE II-Ti™. STALIF C-Ti and MIDLINE II-Ti merge the proven clinical success of STALIF Integrated Interbody technology with Ti-ACTIVE, a texturized titanium coating developed with over 15 years of science and engineering experience. Recently, Centinel Spine received FDA clearance for ALTOS™ PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.

For more information on STALIF L, please visit lateral.centinelspine.com.

About Centinel Spine, Inc.

Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the No- Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.

This information in this press release is intended for audiences in Australia. For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484.887.8813
Email: cs@centinelspine.com

LBL230 R01

 

Centinel Spine® Completes Successful Evaluation of STALIF L™ Minimally-Invasive Lateral Integrated Interbody System

6-20-16_image1New York, NY, June 21, 2016 – Centinel Spine, Inc., (Centinel Spine), the pioneer of the No-Profile®, Integrated Interbody™ fusion device market, completes Alpha release of STALIF L™ No-Profile, lateral lumbar Integrated Interbody device cleared by the U.S. Food and Drug Administration (FDA).

STALIF L continues the thirty-year STALIF® heritage of innovation as STALIF L is the only lateral device to offer the benefits of no-profile, compressive lag fixation with proprietary anti-backout technology and 12-degrees of lordosis. “STALIF L exemplifies our continued commitment to being the gold standard in Integrated Interbody devices,” said John J. Viscogliosi, Chairman & CEO, Centinel Spine. “We are excited to bring the STALIF advantage to minimally-invasive spinal fusion surgery,” Mr. Viscogliosi continued.

In addition to the above-mentioned STALIF benefits, STALIF L also offers a large chamber for bone graft to support fusion, optimized fixation with easily placed self-drilling, self-tapping screws and a variety of cage sizes to match patient anatomy, including a 12-degree lordotic option.

Robert Kimber, MD, Performance Spine Institute, Gulfport, MS, explained, “Over the past year I have used the STALIF L to treat many of my patients in need of minimally-invasive lateral lumbar reconstruction spine surgery. I like the 12 degrees of lordosis and the fixation provided by the screws.”

“STALIF L has the unique feature of compressive lag fixation, which assists me in ensuring that the bony endplates compress the device and bone graft, which I believe to be optimum in accordance with Wolff’s law,” continued Dr. Kimber.

Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C®, STALIF C-Ti™, MIDLINE II™ and MIDLINE II-Ti™. STALIF C-Ti and MIDLINE II-Ti merge the proven clinical success of STALIF Integrated Interbody technology with Ti-ACTIVE™, a texturized titanium coating developed with over 15 years of science and engineering experience.

Upon the completion of its Alpha release with a variety of minimally-invasive retractor options, Centinel Spine begins to release the STALIF L system to spine surgeons in the United States. For more information on STALIF L, please visit lateral.centinelspine.com.

About Centinel Spine, Inc.

Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the No-Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484.887.8813
Email: cs@centinelspine.com

LBL 202 R02

Centinel Spine® Launches MIDLINE II-Ti™ in Australia

hero_midlineii-ti_devicescrewsfluoroNew York, NY, May 26, 2016  Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, launches MIDLINE II-Ti™, a Ti-ACTIVE™ coated, No-Profile, anterior lumbar Integrated Interbody device, in Australia.

“Following the successful MIDLINE II-Ti US launch, we are excited to introduce MIDLINE II-Ti in Australia to complement our STALIF® product offering and bring Ti-ACTIVE to anterior lumbar spinal fusion procedures here,” said John J. Viscogliosi, Chairman & CEO, Centinel Spine.

The MIDLINE II-Ti product family has been available in the United States for just over 9 months with the first clinical implantations by Jessica Shellock, MD, Texas Back Institute®, Plano, TX and James Billys, MD, Florida Orthopaedic Institute®, North Tampa, FL.

MIDLINE II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of STALIF technology. MIDLINE II-Ti blends the STALIF Integrated Interbody advantage with Ti-ACTIVE, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to ALIF procedures with 8° to 20° of lordosis, excellent radiographic visualization, three cancellous screws for stability and an optimal fusion environment.

“We first released Ti-ACTIVE on the STALIF C® product family back in 2014. Since then, Ti-ACTIVE is rapidly increasing our STALIF market share.” said Mr. Viscogliosi. He continued, “Ti-ACTIVE is the culmination of over 15 years of titanium coating science, engineering and experience. And, as with all Centinel Spine technology, Ti-ACTIVE has been designed to satisfy the unmet market need to promote fusion in ALIF procedures. There have been over 4,500 Ti-ACTIVE devices successfully implanted to date.”

“I have used STALIF C-Ti™ over the past year and I look forward to incorporating MIDLINE II-Ti™ into my practice,” said Laurence McEntee, MD, Pindara Hospital, Gold Coast. “I believe that MIDLINE II-Ti will offer my lumbar spine surgery patients the benefits of immediate insertion stability, compression at the graft site and an enhanced fusion environment.”

MIDLINE II-Ti is based upon the STALIF MIDLINE II™ product family. MIDLINE II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the superior biomechanics that have underpinned thirty years of STALIF surgical success. In harmony with Wolff’s law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-ACTIVE coating increases the contact surface area and friction at the bony endplates. To date, over 1,000 MIDLINE II devices have been implanted.

Richard Laherty, MD, Queensland Neurosurgery and Spine, Australia, states, “I choose to use MIDLINE II as it minimizes my surgical incisions and provides a large graft chamber and up to 20° of lordosis for my anterior lumbar fusion procedures. Adding a titanium coating to this device will also provide clear radiographic visualization and a texturized surface for stability and fusion, which are the ultimate goals of my spine surgery procedures.”

Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C, STALIF C-Ti™ for anterior cervical discectomy fusion (ACDF) procedures and STALIF L™ for lateral lumbar interbody fusion (LLIF) procedures. Recently, Centinel Spine received FDA clearance for ALTOS™ PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.

About Centinel Spine, Inc.

Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies.  For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD.   Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.

This information in this press release is intended for audiences in Australia.

For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484.887.8813
Email: cs@centinelspine.com

LBL 216 R01

Centinel Spine® Expands STALIF® Internationally

hero_midlineii-ti_devicescrewsfluoro
New York, NY, May 24, 2016 Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti™ product family, a Ti-ACTIVE™-coated, No-Profile, anterior lumbar Integrated Interbody device, in the United States and Australia.

MIDLINE II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of STALIF® technology.  MIDLINE II-Ti blends the STALIF Integrated Interbody advantage with Ti-ACTIVE, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to ALIF procedures with 8°,12°,16° and 20° of lordosis, excellent radiographic visualization and three cancellous screws for optimum stability.

“This expansion is enabling Centinel Spine to rapidly increase market share and represents another key milestone in our Ti-ACTIVE product portfolio,” said John J. Viscogliosi, Chairman & CEO, Centinel Spine.  “Ti-ACTIVE is the culmination of over 15 years of titanium coating science, engineering and experience.  And, as with all Centinel Spine technology, Ti-ACTIVE has been designed to satisfy unmet market needs.  There have been over 4,500 Ti-ACTIVE devices successfully implanted to date.”

MIDLINE II-Ti is based upon the STALIF MIDLINE II™ product family.  MIDLINE II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the superior biomechanics that have underpinned thirty years of STALIF surgical success.  In harmony with Wolff’s law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-ACTIVE coating increases the contact surface area and friction at the bony endplates. To date around 1,000 MIDLINE II devices have been implanted.

Gunwant Mallik, MD, Columbus, OH, states “The compressive fixation provided by the three lag screws, lordosis options and size options are very important. The titanium-coated PEEK option provides additional surface area that enhances stability.” Additionally Jon White, MD, HOAG Orthopedic Institute, Irvine, CA commented “MIDLINE II represents the best ALIF device currently on the market due to the overall simplicity, dependability and comprehensive design rationale”.

Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C®, STALIF C-Ti™ for anterior cervical discectomy fusion (ACDF) procedures and STALIF L™ for lateral lumbar interbody fusion (LLIF) procedures.  Recently, Centinel Spine received FDA clearance for ALTOS™ PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.

About Centinel Spine, Inc.

Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies.  For more information on Centinel Spine products and technologies, please visit the Company’s web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD.   Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the “Sentinel Sign” – the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484.887.8813
Email: cs@centinelspine.com

LBL 216 R01